Oracle Stock Plunges 4.23% to 2025 Low on Mixed Earnings, Institutional Divestments, Insider Sales

The share price fell to its lowest level since September 2025 today, with an intraday decline of 4.23%.

Oracle’s recent downturn reflects a confluence of institutional divestments, insider selling, and mixed earnings results. Institutional investors displayed divergent strategies, with Tobam cutting its stake by 61.3% in Q2 2025, while KBC Group NV boosted holdings by 58.8%. Insider sales totaling $60.23 million over 90 days, including significant reductions by executives like CEO Clayton Magouyrk, further pressured sentiment. Quarterly earnings showed a $0.01 miss on EPS despite 12.2% year-over-year revenue growth, underscoring operational headwinds.

Analysts remain split, with a “Moderate Buy” consensus but wide-ranging price targets from $175 to $400. Oracle’s high P/E ratio of 54.62 and PEG of 2.96 highlight valuation concerns, while a debt-to-equity ratio of 3.33 signals leverage risks. Despite a 0.8% dividend yield, the stock trades below its 52-week high, reflecting investor caution. Oracle’s dominance in enterprise SaaS remains intact, but the lack of recent strategic expansions and reliance on legacy revenue streams amplify uncertainty. Institutional optimism from KBC Group contrasts with insider caution, creating a volatile outlook as the market weighs growth potential against structural challenges.